Phillip Cowley

Directeur/Membre du Conseil chez Duke Street Bio Ltd.

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Alan Wisee	M	-	Duke Street Bio Ltd. Duke Street Bio Ltd. BiotechnologyHealth Technology Duke Street Bio Ltd. is a British precision medicine company that targets specific genetic alterations in cancer using a DDR vulnerability approach. The company is based in London, UK. The company's goal is to deliver life-saving cancer treatments to improve patient outcomes. The company was founded in 2020. The CEO is Alan Wisee.	-
Peter Trill	M	-	Duke Street Bio Ltd. Duke Street Bio Ltd. BiotechnologyHealth Technology Duke Street Bio Ltd. is a British precision medicine company that targets specific genetic alterations in cancer using a DDR vulnerability approach. The company is based in London, UK. The company's goal is to deliver life-saving cancer treatments to improve patient outcomes. The company was founded in 2020. The CEO is Alan Wisee.	-
Harvey Andrew McGrath	M	72	Duke Street Bio Ltd. Duke Street Bio Ltd. BiotechnologyHealth Technology Duke Street Bio Ltd. is a British precision medicine company that targets specific genetic alterations in cancer using a DDR vulnerability approach. The company is based in London, UK. The company's goal is to deliver life-saving cancer treatments to improve patient outcomes. The company was founded in 2020. The CEO is Alan Wisee.	-
Donnie Gene Christian	M	85	Duke Street Bio Ltd. Duke Street Bio Ltd. BiotechnologyHealth Technology Duke Street Bio Ltd. is a British precision medicine company that targets specific genetic alterations in cancer using a DDR vulnerability approach. The company is based in London, UK. The company's goal is to deliver life-saving cancer treatments to improve patient outcomes. The company was founded in 2020. The CEO is Alan Wisee.	-